Background The incidence of inflammatory bowel disease (IBD) is rising worldwide, though
the differences in health care utilization among different races and ethnicities remains …

Background: Race and socioeconomic status (SES) significantly affect the content and
delivery of healthcare for multiple chronic disease states. Inflammatory bowel disease (IBD) …

Background & Aims Inflammatory bowel diseases (IBDs)(Crohn's disease [CD], ulcerative
colitis) are global diseases. Similarities and differences in disease presentation and …

Background While the incidence of inflammatory bowel disease (IBD) among African-
Americans (AAs) is increasing, there is limited understanding of phenotypic differences and …

Although Crohn's disease (CD) and ulcerative colitis (UC) have been considered as
disorders that affect individuals of European ancestry, the epidemiology of the inflammatory …

Background Prior studies have identified racial disparities in the treatment and outcomes of
inflammatory bowel disease (IBD). These disparities could be secondary to differences in …

Background Inflammatory bowel disease (IBD) has predominantly affected whites,
particularly Ashkenazi Jews. Over the last 2 decades, IBD has “emerged” in minorities …

OBJECTIVES: Optimization of medical therapy and specialist care for inflammatory bowel
disease (IBD) may reduce morbidity. We sought to characterize racial disparities in …

Background Previous reports have shown differences in phenotypes among black patients
with inflammatory bowel disease (IBD) compared with other racial groups, but prior studies …

Background: IBD-related hospitalizations contribute to significant morbidity and health care
economic burden. Methods: IBD-related hospitalizations (identified with ICD-9) among US …